- Home
- WORX vs SNPX Comparison
WORX vs SNPX Comparison
Compare WORX & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- SNPX
- Stock Information
- Founded
- WORX N/A
- SNPX 2012
- Country
- WORX United States
- SNPX United States
- Employees
- WORX N/A
- SNPX N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- WORX Consumer Discretionary
- SNPX Health Care
- Exchange
- WORX Nasdaq
- SNPX Nasdaq
- Market Cap
- WORX 3.4M
- SNPX 3.7M
- IPO Year
- WORX N/A
- SNPX N/A
- Fundamental
- Price
- WORX $1.41
- SNPX $2.57
- Analyst Decision
- WORX
- SNPX Strong Buy
- Analyst Count
- WORX 0
- SNPX 1
- Target Price
- WORX N/A
- SNPX $14.00
- AVG Volume (30 Days)
- WORX 7.8M
- SNPX 13.5K
- Earning Date
- WORX 11-14-2024
- SNPX 11-12-2024
- Dividend Yield
- WORX N/A
- SNPX N/A
- EPS Growth
- WORX N/A
- SNPX N/A
- EPS
- WORX N/A
- SNPX N/A
- Revenue
- WORX $3,224,146.00
- SNPX N/A
- Revenue This Year
- WORX N/A
- SNPX N/A
- Revenue Next Year
- WORX N/A
- SNPX N/A
- P/E Ratio
- WORX N/A
- SNPX N/A
- Revenue Growth
- WORX N/A
- SNPX N/A
- 52 Week Low
- WORX $0.75
- SNPX $2.32
- 52 Week High
- WORX $4.44
- SNPX $8.78
- Technical
- Relative Strength Index (RSI)
- WORX 42.76
- SNPX 40.67
- Support Level
- WORX $1.80
- SNPX $2.52
- Resistance Level
- WORX $2.16
- SNPX $2.80
- Average True Range (ATR)
- WORX 0.20
- SNPX 0.21
- MACD
- WORX -0.10
- SNPX -0.02
- Stochastic Oscillator
- WORX 0.00
- SNPX 7.35
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.